CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Coumarin

香豆素 杂质对照品Coumarin Impurities

24 个杂质条目24 impurity entries

本页汇总 香豆素 的 24 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 24 impurity reference standards of Coumarin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 香豆素(Coumarin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesProtective effects and DNA repair induction of a coumarin-chalcone hybrid against genotoxicity induced by mutagens
    Journal of toxicology and environmental health. Part A · 2022 · Véras JH et al.  ·  PMID 36068785  ·  DOI
  2. 杂质研究Impurity studiesStability and Extraction of Vanillin and Coumarin under Subcritical Water Conditions
    Molecules (Basel, Switzerland) · 2020 · Doctor N et al.  ·  PMID 32120972  ·  DOI
  3. 杂质研究Impurity studiesHPLC analysis and safety assessment of coumarin in foods
    Food chemistry · 2008 · Sproll C et al.  ·  PMID 26003373  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of a Quinoline-Coumarin Fluorescent Probe and its Applications
    Journal of fluorescence · 2025 · Wang M et al.  ·  PMID 40153235  ·  DOI
  • 合成方法SynthesisBiocatalytic Synthesis of Coumarin S-Glycosides: Towards Non-Cytotoxic Probes for Biomedical Imaging and Sensing
    Molecules (Basel, Switzerland) · 2024 · Burrini N et al.  ·  PMID 38542958  ·  DOI

香豆素 —— 原料药与杂质对照品Coumarin — drug substance & impurities

共 25 个条目(含原料药本体)25 items incl. the drug substance
Coumarin structure
原料药 APIAPI
香豆素Coumarin
Coumarin
CAS No.91-64-5
Chemical FormulaC9H6O2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 1 structure
1
香豆素杂质1Coumarin Impurity 1
Coumarin Impurity 1
CAS No.91-44-1
Chemical FormulaC14H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 2 (Coumarin 2) structure
2
香豆素杂质2 (香豆素2)Coumarin Impurity 2 (Coumarin 2)
Coumarin Impurity 2 (Coumarin 2)
CAS No.26078-25-1
Chemical FormulaC13H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 3 (Coumarin 6) structure
3
香豆素杂质3 (香豆素6)Coumarin Impurity 3 (Coumarin 6)
Coumarin Impurity 3 (Coumarin 6)
CAS No.38215-36-0
Chemical FormulaC20H18N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 4 (Coumarin 6H) structure
4
香豆素杂质4 (香豆素6H)Coumarin Impurity 4 (Coumarin 6H)
Coumarin Impurity 4 (Coumarin 6H)
CAS No.58336-35-9
Chemical FormulaC15H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 5 (Coumarin 7) structure
5
香豆素杂质5 (香豆素7)Coumarin Impurity 5 (Coumarin 7)
Coumarin Impurity 5 (Coumarin 7)
CAS No.27425-55-4
Chemical FormulaC20H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 6 structure
6
香豆素杂质6Coumarin Impurity 6
Coumarin Impurity 6
CAS No.1786-05-6
Chemical FormulaC15H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 7 structure
7
香豆素杂质7Coumarin Impurity 7
Coumarin Impurity 7
CAS No.531-59-9
Chemical FormulaC10H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 8 structure
8
香豆素杂质8Coumarin Impurity 8
Coumarin Impurity 8
CAS No.6093-67-0
Chemical FormulaC9H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 9 (Coumarin 30) structure
9
香豆素杂质9 (香豆素30)Coumarin Impurity 9 (Coumarin 30)
Coumarin Impurity 9 (Coumarin 30)
CAS No.41044-12-6
Chemical FormulaC21H21N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 10 (Coumarin 102) structure
10
香豆素杂质10 (香豆素102)Coumarin Impurity 10 (Coumarin 102)
Coumarin Impurity 10 (Coumarin 102)
CAS No.41267-76-9
Chemical FormulaC16H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 11 (Esculetin) structure
11
香豆素杂质11 (秦皮乙素)Coumarin Impurity 11 (Esculetin)
Coumarin Impurity 11 (Esculetin)
CAS No.305-01-1
Chemical FormulaC9H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 12 structure
12
香豆素杂质12Coumarin Impurity 12
Coumarin Impurity 12
CAS No.87-05-8
Chemical FormulaC12H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 14 structure
14
香豆素杂质14Coumarin Impurity 14
Coumarin Impurity 14
CAS No.66187-15-3
Chemical FormulaC6H7ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 15 structure
15
香豆素杂质15Coumarin Impurity 15
Coumarin Impurity 15
CAS No.117038-82-1
Chemical FormulaC21H20O6
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 16 structure
16
香豆素杂质16Coumarin Impurity 16
Coumarin Impurity 16
CAS No.42286-88-4
Chemical FormulaC11H10O2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 17 structure
17
香豆素杂质17Coumarin Impurity 17
Coumarin Impurity 17
CAS No.94805-82-0
Chemical FormulaC21H20O6
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 18 structure
18
香豆素杂质18Coumarin Impurity 18
Coumarin Impurity 18
CAS No.500-05-0
Chemical FormulaC6H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 19 structure
19
香豆素杂质19Coumarin Impurity 19
Coumarin Impurity 19
CAS No.10387-50-5
Chemical FormulaC14H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 20 structure
20
香豆素杂质20Coumarin Impurity 20
Coumarin Impurity 20
CAS No.1386351-29-6
Chemical FormulaC12H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 21 structure
21
香豆素杂质21Coumarin Impurity 21
Coumarin Impurity 21
CAS No.21860-31-1
Chemical FormulaC14H14O4
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 22 structure
22
香豆素杂质22Coumarin Impurity 22
Coumarin Impurity 22
CAS No.6022-36-2
Chemical FormulaC20H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 23 structure
23
香豆素杂质23Coumarin Impurity 23
Coumarin Impurity 23
CAS No.20853-56-9
Chemical FormulaC15H16O9
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 24 structure
24
香豆素杂质24Coumarin Impurity 24
Coumarin Impurity 24
CAS No.1013-69-0
Chemical FormulaC10H8O4
Purity>95%询价On request
10mg25mg50mg100mg
Coumarin Impurity 25 (Inflacoumarin A) structure
25
香豆素杂质25 (胀果香豆素甲)Coumarin Impurity 25 (Inflacoumarin A)
Coumarin Impurity 25 (Inflacoumarin A)
CAS No.158446-33-4
Chemical FormulaC20H18O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

香豆素 —— 研究文献与合成路线Coumarin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 香豆素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Coumarin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs
    Zeng Y, Xiao J, Xu Y, et al. · Journal of medicinal chemistry · 2023 · 被引 31cited 31
  2. Elucidation of the coumarin degradation by Pseudomonas sp. strain NyZ480
    Gu Y, Li T, Yin CF, et al. · Journal of hazardous materials · 2023 · 被引 9cited 9
  3. Isolation, Identification and Characterization of Growth Parameters of Pseudomonas putida HSM-C2 with Coumarin-Degrading Bacteria
    Huang S, Wang M, Mao D, et al. · Molecules (Basel, Switzerland) · 2022 · 被引 7cited 7
  4. Elucidating the role of the genus Pseudomonas involved in coumarin degradation
    Hu S, Lu P, Feng Y, et al. · Environmental research · 2025 · 被引 3cited 3
  5. Discovery of an NF-κB1 p105 Degrader for Anti-Inflammatory Therapy via Structural Optimization of the Coumarin Natural Product Minutuminolate
    Choo MZY, Lim ET, Wong WSF, et al. · Journal of medicinal chemistry · 2025 · 被引 3cited 3
  6. The natural coumarin 7-methoxy-8-isopentenyloxycoumarin alleviates LPS-induced inflammation by suppressing NF-κB and the MAPK/AP-1 pathways and accelerating COX-2 proteasomal degradation
    Huang SW, Chen HC, Lupia A, et al. · European journal of pharmacology · 2026

合成与制备工艺专利Synthesis & process patents

  1. NOVEL COUMARIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND KITS COMPRISING THE COUMARIN DERIVATIVES FOR FLUORESCENT IMMUNOSORBANT ASSAY
    PARK HYUN, CHONG CHOM KYU, KIM HAK SUNG, KIM SUNG YEON, et al. · 公开号 KR20110097092KR20110097092 · 2011
  2. PROCESS FOR PRODUCING COUMARIN COMPOUND
    HASHIMOTO TOMOHIRO, HAYASHI KATSUYUKI · 公开号 WO2012050147WO2012050147 · 2012
  3. NEW COUMARIN DERIVATIVE AND PROCESS FOR PREPARING THE SAME
    RYU BYUNG JU, KANG SU YEON, KIM HYO JEONG, LEE JIN WOO, et al. · 公开号 KR20120018428KR20120018428 · 2012
  4. 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use
    HEPING ZENG, WEIWEI MAO, TINGTING WANG · 公开号 CN101497593CN101497593 · 2009
  5. COUMARIN COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND PROCESS FOR PREPARING THE SAME
    PARMAR VIRENDER SINGH, RAJ HANUMANTHRAO GURU, PRASAD ASHOK KUMAR, JAIN SUBHASH CHAND · 公开号 WO2009157020WO2009157020 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

香豆素 杂质谱研究要点Coumarin — impurity profiling notes

下面这些是拿到 香豆素 的 25 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 25 impurity entries for Coumarin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances